Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. GOCO
GOCO logo

GOCO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Gohealth Inc (GOCO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
1.840
1 Day change
-11.11%
52 Week Range
14.630
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Gohealth Inc (GOCO) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with sharp declines in revenue, net income, EPS, and gross margin. Technical indicators suggest a bearish trend, and there are no positive catalysts or trading signals to support a buy decision. Additionally, there is no recent news, analyst updates, or congressional trading data to provide a compelling reason to invest in this stock.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting an overall downward trend. Key support and resistance levels show limited upside potential, with resistance at 1.783 and support at 1.353.

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

  • The company's financial performance is extremely poor, with a 71.10% YoY revenue drop, a 2950.91% YoY decline in net income, and a gross margin of -27.56%. Additionally, stock trend analysis predicts a negative performance in the next week (-1.72%) and month (-5.96%).

Financial Performance

In Q3 2025, the company reported a sharp decline in revenue (-71.10% YoY), net income (-2950.91% YoY), EPS (-2665.22% YoY), and gross margin (-143.42% YoY). These metrics indicate severe financial distress.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast GOCO stock price to rise
3 Analyst Rating
Wall Street analysts forecast GOCO stock price to rise
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 2.070
sliders
Low
5
Averages
7.5
High
10
Current: 2.070
sliders
Low
5
Averages
7.5
High
10
RBC Capital
Sector Perform
downgrade
$12 -> $5
AI Analysis
2025-11-26
Reason
RBC Capital
Price Target
$12 -> $5
AI Analysis
2025-11-26
downgrade
Sector Perform
Reason
RBC Capital lowered the firm's price target on GoHealth to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following the company's Q3 results, which came in significantly below expectations due to topline weakness as a result of one large carrier suspending its relationship with, the analyst tells investors in a research note.
William Blair
Outperform -> Market Perform
downgrade
2025-11-18
Reason
William Blair
Price Target
2025-11-18
downgrade
Outperform -> Market Perform
Reason
William Blair downgraded GoHealth to Market Perform from Outperform.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GOCO
Unlock Now

People Also Watch